# Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty

> **NCT01527968** · NA · UNKNOWN · sponsor: **Heekin Orthopedic Research Institute** · enrollment: 54 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Epsilon Aminocaproic Acid
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01527968
- **Lead sponsor:** Heekin Orthopedic Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527968, "Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01527968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*